CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies
Clinical trial NCT07106749 · RECRUITING
Trial details
- NCT number
- NCT07106749
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-28
- Primary completion
- 2028-06-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.